Medistep Healthcare Peer Comparison

NSE: MEDISTEP

₹20.50

₹0.00 (0.00%)

As on 06-Oct-2026 12:01IST

Market cap

₹29 Cr

Revenue (TTM)

₹71 Cr

P/E Ratio

4.9

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Market cap (₹ Cr)	29	7,486	31	33	25
Revenue (₹ Cr)	71	7,128	13	31	366
Net Profit (₹ Cr)	5.98	167.66	-1.78	4.12	-16.99
Net Margin (%)	8.44	2.35	-8.71	13.20	-4.63
RoE (%)	21.69	7.58	-1.56	39.41	-14.35
Price to Earnings	4.87	59.69	--	7.92	--
Price-To-Book	0.77	4.32	0.28	2.15	0.26

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Operating Revenue	70.83	6,591.21	12.45	31.20	--
Total Income	70.85	6,610.45	20.66	31.20	--
Total Expenditure	62.57	6,325.26	21.85	24.12	--
EBITDA	8.26	265.96	-9.40	7.08	--
Depreciation	0.03	43.29	1.81	0.24	--
EBIT	8.23	222.66	-11.21	6.84	--
Interest	0.26	54.39	0.02	1.46	--
Other Income	0.02	19.24	8.21	0.00	--
Exceptional Items	--	-8.18	--	--	--
Profit before Tax	8.00	179.34	-3.02	5.39	--
Provision for Tax	2.01	33.50	0.01	1.27	--
Profit after Tax	5.98	145.84	-3.04	4.12	--

Liabilities (₹ Cr)

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Shareholder's Funds	37.82	1,688.61	111.61	14.25	--
Minority Interest	--	63.94	--	--	--
Non-Current Liabilities	0.02	206.12	1.14	2.43	--
Current Liabilities	12.45	1,587.57	2.71	12.11	--
Total Liabilities	50.30	3,600.22	115.46	28.87	--

Assets (₹ Cr)

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Non-Current Assets	0.13	1,037.80	68.44	2.75	--
Current Assets	50.16	2,503.13	47.02	26.05	--
Total Assets	50.30	3,600.22	115.46	28.87	--
Total Debt*	5.18	566.68	0.00	9.16	--
Net Current Assets	37.71	915.56	44.31	13.93	--
Contingent Liabilities	--	5.51	--	3.37	--

Cashflow (₹ Cr)

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Cash From Operating Activities	-19.48	96.20	-7.02	2.81	--
Cash Flow from Investing Activities	-0.01	-303.06	7.11	-0.06	--
Cash from Financing Activities	18.79	123.66	--	-3.40	--
Net Cash Inflow / Outflow	-0.70	-83.20	0.09	-0.65	--

Ratios

Profitability Ratios

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
ROCE (%)	27.06	10.93	-2.58	30.60	--
ROE (%)	21.69	8.57	-2.61	39.41	--
ROA (%)	16.33	4.68	-2.52	14.98	--
EBIT Margin (%)	11.69	4.33	-9.59	22.70	--
Net Margin (%)	8.44	2.21	-14.70	13.20	--
Cash Profit Margin (%)	8.48	2.87	-9.88	13.97	--

Growth Ratios

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Revenue Growth (%)	42.65	29.35	-51.14	11.20	--
EBIT Growth (%)	47.48	35.13	-229.03	16.95	--
Net Profit Growth (%)	44.38	35.75	-431.96	45.26	--
EPS Growth (%)	6.34	21.32	-431.95	45.26	--
Book Value Growth (%)	117.98	-2.19	-7.97	47.19	--

Valuation Ratios

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Price / Earnings	3.92	47.12	0.00	0.00	--
Price / Book Value	0.62	3.22	0.26	0.00	--
Dividend Yield (%)	0.00	0.00	0.00	--	--
EV/EBITDA	3.38	20.43	-23.82	2.44	--
Market Cap (₹ Cr)	23.45	5,420.61	28.93	0.00	--

Solvency Ratios

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Debt to Equity	0.14	0.34	0.00	0.64	--
Short term debt to equity ratio	0.14	0.26	--	0.42	--
Current Ratio	4.03	1.58	17.34	2.15	--
Quick Ratio	3.53	1.05	16.26	1.64	--
Interest Coverage	31.94	4.30	-137.05	4.70	--

Operating Efficiency Ratios

	Medistep Healthcare	Entero Health	Medi-Caps	Goldline Pharmaceutical	Welcure Drugs
Debtors to sales (%)	55.61	18.39	55.60	51.70	--
Asset Turnover	1.93	2.11	0.10	1.13	--
Receivable days	153.31	56.56	230.34	156.90	--
Inventory Days	18.75	41.57	90.05	75.99	--
Payable days	18.03	34.66	71.74	64.86	--
Cash Conversion Cycle	154.03	63.47	248.65	168.03	--

Annual
Quarterly